ApmA Is a Unique Aminoglycoside Antibiotic Acetyltransferase That Inactivates Apramycin
Apramycin is an aminoglycoside antibiotic that has been traditionally used in veterinary medicine. Recently, it has become an attractive candidate to repurpose in the fight against multidrug-resistant pathogens prioritized by the World Health Organization.
Guardado en:
Autores principales: | Emily Bordeleau, Peter J. Stogios, Elena Evdokimova, Kalinka Koteva, Alexei Savchenko, Gerard D. Wright |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41564d3daac1455389836743598c7dac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural and Molecular Basis for Resistance to Aminoglycoside Antibiotics by the Adenylyltransferase ANT(2″)-Ia
por: Georgina Cox, et al.
Publicado: (2015) -
The evolution of substrate discrimination in macrolide antibiotic resistance enzymes
por: Andrew C. Pawlowski, et al.
Publicado: (2018) -
Rifampin phosphotransferase is an unusual antibiotic resistance kinase
por: Peter J. Stogios, et al.
Publicado: (2016) -
Thermodynamic Studies of Aminoglycoside Antibiotic-Enzyme Interactions
por: Engin H. Serpersu, et al.
Publicado: (2006) -
Structural and biochemical analyses of an aminoglycoside 2′-N-acetyltransferase from Mycolicibacterium smegmatis
por: Chang-Sook Jeong, et al.
Publicado: (2020)